197 related articles for article (PubMed ID: 20687873)
1. Epitope discovery and their use in peptide based vaccines.
Dudek NL; Perlmutter P; Aguilar MI; Croft NP; Purcell AW
Curr Pharm Des; 2010; 16(28):3149-57. PubMed ID: 20687873
[TBL] [Abstract][Full Text] [Related]
2. More than one reason to rethink the use of peptides in vaccine design.
Purcell AW; McCluskey J; Rossjohn J
Nat Rev Drug Discov; 2007 May; 6(5):404-14. PubMed ID: 17473845
[TBL] [Abstract][Full Text] [Related]
3. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
4. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
Tsoras AN; Wong KM; Paravastu AK; Champion JA
Front Immunol; 2020; 11():1547. PubMed ID: 32849524
[TBL] [Abstract][Full Text] [Related]
6. Peptidomimetics: modifying peptides in the pursuit of better vaccines.
Croft NP; Purcell AW
Expert Rev Vaccines; 2011 Feb; 10(2):211-26. PubMed ID: 21332270
[TBL] [Abstract][Full Text] [Related]
7. Peptide vaccines in breast cancer: The immunological basis for clinical response.
Peres Lde P; da Luz FA; Pultz Bdos A; Brígido PC; de Araújo RA; Goulart LR; Silva MJ
Biotechnol Adv; 2015 Dec; 33(8):1868-77. PubMed ID: 26523780
[TBL] [Abstract][Full Text] [Related]
8. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations.
Gras-Masse H
Mol Immunol; 2001 Dec; 38(6):423-31. PubMed ID: 11741692
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of peptide selection approaches for epitope-based vaccine design.
Schubert B; Lund O; Nielsen M
Tissue Antigens; 2013 Oct; 82(4):243-51. PubMed ID: 24461003
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Slingluff CL; Petroni GR; Chianese-Bullock KA; Smolkin ME; Hibbitts S; Murphy C; Johansen N; Grosh WW; Yamshchikov GV; Neese PY; Patterson JW; Fink R; Rehm PK
Clin Cancer Res; 2007 Nov; 13(21):6386-95. PubMed ID: 17975151
[TBL] [Abstract][Full Text] [Related]
11. Immune peptide enhancement of peptide based vaccines.
Rosenthal KS
Front Biosci; 2005 Jan; 10():478-82. PubMed ID: 15574384
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based vaccines for cancer therapy.
Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
[TBL] [Abstract][Full Text] [Related]
13. Computer aided subunit vaccine design against pathogenic Leptospira serovars.
Umamaheswari A; Pradhan D; Hemanthkumar M
Interdiscip Sci; 2012 Mar; 4(1):38-45. PubMed ID: 22392275
[TBL] [Abstract][Full Text] [Related]
14. Composite peptide-based vaccines for cancer immunotherapy (Review).
Yang J; Zhang Q; Li K; Yin H; Zheng JN
Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
[TBL] [Abstract][Full Text] [Related]
15. Multipeptide vaccination in cancer patients.
Pilla L; Rivoltini L; Patuzzo R; Marrari A; Valdagni R; Parmiani G
Expert Opin Biol Ther; 2009 Aug; 9(8):1043-55. PubMed ID: 19591629
[TBL] [Abstract][Full Text] [Related]
16. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
17. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
[TBL] [Abstract][Full Text] [Related]
18. Peptide vaccines against cancer, infectious diseases, and conception.
Naz RK; Dabir P
Front Biosci; 2007 Jan; 12():1833-44. PubMed ID: 17127424
[TBL] [Abstract][Full Text] [Related]
19. Getting peptide vaccines to work: just a matter of quality control?
Celis E
J Clin Invest; 2002 Dec; 110(12):1765-8. PubMed ID: 12488425
[No Abstract] [Full Text] [Related]
20. Immunogenically fit subunit vaccine components via epitope discovery from natural peptide libraries.
Matthews LJ; Davis R; Smith GP
J Immunol; 2002 Jul; 169(2):837-46. PubMed ID: 12097387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]